Brief: Xbrane Carries Out Directed Share Issue, Issue Of Convertible Bonds

Xbrane Biopharma AB

23/05/2023 07:58

May 23 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * RESOLVED ON DIRECTED SHARE ISSUE OF APPROXIMATELY SEK 125
MILLION AT SUBSCRIPTION PRICE OF SEK 73.1 PER SHARE
    * IN CONNECTION WITH DIRECTED SHARE ISSUE, CO HAS ENTERED
INTO A
BINDING AGREEMENT WITH CVI INVESTMENTS FOR CONVERTIBLE BOND
FINANCING OF SEK 250 MILLION IN AGGREGATE PRINCIPAL AMOUNT,
MATURING IN 2027
    * NUMBER OF SWEDISH, INTERNATIONAL INSTITUTIONAL INVESTORS,
INCLUDING HEALTHCARE FOCUSED INVESTORS, HAVE SUBSCRIBED FOR
SHARES IN DIRECTED SHARE ISSUE

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN66hY7p, urn:newsml:reuters.com:*:nMFN7jhkcV
 Further company coverage:  XBRANE.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))